Turnhout, Belgium

Koen Karel Jansen

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 27.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Koen Karel Jansen: Innovator in Pharmaceutical Chemistry

Introduction

Koen Karel Jansen is a notable inventor based in Turnhout, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of five patents to his name, Jansen's work is recognized for its potential impact on medical treatments.

Latest Patents

Jansen's latest patents include the invention of N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and their methods of use. These compounds are designed to be effective agents in treating diseases and conditions mediated by CFTR, such as cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. The patents also encompass pharmaceutical compositions that include one or more of these compounds, highlighting their therapeutic potential.

Career Highlights

Throughout his career, Jansen has worked with prominent companies in the pharmaceutical industry, including Galapagos NV and AbbVie S.à r.l. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Jansen has collaborated with several professionals in his field, including Rhalid Akkari and Luke Jonathan Alvey. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Koen Karel Jansen's contributions to pharmaceutical chemistry through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to hold promise for the treatment of various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…